Holen Sie sich die Stockscreener-App
234.31
2.19%
-5.25
Handel nachbörslich:
234.31
Natera Inc Aktie (NTRA) Neueste Nachrichten
Natera (NTRA) announces publication of findings from randomized, phase III CALGB (Alliance)/SWOG 80702 study - MSN
Non-Invasive Prenatal Testing Market is expected to generate a revenue of USD 9.83 Billion by 2031, Globally, at 17.01% CAGR: Verified Market Research® - GlobeNewswire Inc.
Will Natera Inc. stock outperform tech sector in 2025Insider Buying & Real-Time Stock Entry Alerts - ulpravda.ru
Can Natera Inc. stock sustain market leadership2025 AllTime Highs & Risk Controlled Stock Pick Alerts - ulpravda.ru
Is Natera Inc. stock attractive for growth ETFs2025 Top Gainers & Free High Accuracy Swing Entry Alerts - ulpravda.ru
Will Natera Inc. stock gain from strong economyQuarterly Portfolio Report & Risk Adjusted Buy/Sell Alerts - ulpravda.ru
Can Natera Inc. stock weather global recessionJuly 2025 Momentum & Reliable Entry Point Alerts - ulpravda.ru
Can Natera Inc. stock beat analyst upgradesJuly 2025 Opening Moves & Real-Time Chart Pattern Alerts - ulpravda.ru
EXEL Collaborates With Natera for Late-Stage Colorectal Cancer Study - Finviz
Assessing Natera (NTRA) Valuation After Positive ALTAIR Trial Data And Expanded Fetal Focus Test Launch - simplywall.st
Medical stock hovers near buy point after 46% gain - MSN
Why Natera’s Stock Is Sliding Despite Bullish Outlook - TipRanks
Trade Tracker: Stephanie Link sells Eaton and buys more Zoetis, Natera - CNBC
Exelixis and Natera stocks rise on colorectal cancer trial collaboration By Investing.com - Investing.com South Africa
Exelixis and Natera stocks rise on colorectal cancer trial collaboration - Investing.com
Exelixis, Natera to Collaborate on Phase 3 Colorectal Cancer Trial - MarketScreener
Exelixis and Natera to collaborate on Stellar-316, a phase 3 pivotal trial of zanzalintinib - MarketScreener
Insiders At Natera Sold US$47m In Stock, Alluding To Potential Weakness - Yahoo Finance
Citigroup Initiates Buy Rating on Natera (NTRA) with $300 Price Target | NTRA Stock News - GuruFocus
Exelixis and Natera to collaborate on MRD-guided cancer trial By Investing.com - Investing.com Australia
Exelixis and Natera to Collaborate on STELLAR-316, a Phase 3 Pivotal Trial of Zanzalintinib for Patients with Colorectal Cancer - Yahoo Finance
Natera: Leading MRD Position, Expanding Margins, and Premium Valuation Support Buy Rating and $300 Target - TipRanks
Natera Inc: President Moshkevich sells $675k in stock By Investing.com - Investing.com South Africa
Natera Inc: President Moshkevich sells $675k in stock - Investing.com India
Natera Inc stock hits all-time high at 247.0 USD - Investing.com
Expanded Fetal Test and Stronger ALTAIR Signal Could Be A Game Changer For Natera (NTRA) - simplywall.st
Natera Presents Updated Analyses From ALTAIR Clinical Trial at ASCO GI - The AI Journal
NTRA Gains Momentum as Guggenheim Raises Price Target to $270 | - GuruFocus
Natera Launches 21-Gene Fetal Focus™ Single-Gene NIPT, Powered By Ultra-Sensitive LinkedSNP™ Technology - Yahoo Finance
Is Natera (NASDAQ:NTRA) A Risky Investment? - 富途牛牛
Natera (NASDAQ:NTRA) Upgraded at Zacks Research - MarketBeat
Exploring 3 High Growth Tech Stocks In The US Market - simplywall.st
Calamos Advisors LLC Has $930,000 Holdings in Natera, Inc. $NTRA - MarketBeat
Responsive Playbooks and the NTRA Inflection - Stock Traders Daily
Ninety One UK Ltd Sells 218,812 Shares of Natera, Inc. $NTRA - MarketBeat
Allspring Global Investments Holdings LLC Sells 47,131 Shares of Natera, Inc. $NTRA - MarketBeat
Miami man arrested in nearly $1 million theft from tech company he worked for: Cops - NBC 6 South Florida
Natera (NTRA) Announces Publication of Findings from Randomized, Phase III CALGB (Alliance)/SWOG 80702 Study - Finviz
Miami man accused of stealing nearly $1 million from 2 South Florida businesses - WPLG Local 10
Natera, Inc. (NASDAQ:NTRA) Short Interest Update - MarketBeat
Natera CFO sells shares worth $7.76 million - MSN
Medical Stock Hovers Near Buy Point After 46% Gain - Investor's Business Daily
Analysts Are Bullish on These Healthcare Stocks: Natera (NTRA), Immunome (IMNM) - The Globe and Mail
Cwm LLC Increases Stake in Natera, Inc. $NTRA - MarketBeat
Vontobel Holding Ltd. Increases Stock Position in Natera, Inc. $NTRA - MarketBeat
Natera is Transforming Patient Care Using AI - Amazon Web Services (AWS)
Natera: Is Signatera’s Momentum About to Accelerate Again as Biomarker Laws Expand State by State? - Smartkarma
Natera, Inc. $NTRA Shares Bought by SWS Partners - MarketBeat
Is Natera’s 486% Three Year Surge Still Justified by Its Fundamentals? - Yahoo Finance
1.36%
0.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):